Amphastar Pharmaceuticals, Inc.
AMPH
$30.50
$0.842.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.28% | -8.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.28% | -8.58% | |||
| Cost of Revenue | 3.10% | -14.62% | |||
| Gross Profit | 1.45% | -1.61% | |||
| SG&A Expenses | -13.05% | 19.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.75% | -5.76% | |||
| Operating Income | 13.12% | -17.39% | |||
| Income Before Tax | 27.45% | -29.80% | |||
| Income Tax Expenses | 48.92% | -7.02% | |||
| Earnings from Continuing Operations | 22.72% | -33.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.72% | -33.40% | |||
| EBIT | 13.12% | -17.39% | |||
| EBITDA | 11.59% | -13.11% | |||
| EPS Basic | 24.53% | -32.93% | |||
| Normalized Basic EPS | 29.32% | -29.30% | |||
| EPS Diluted | 25.49% | -31.03% | |||
| Normalized Diluted EPS | 32.13% | -27.81% | |||
| Average Basic Shares Outstanding | -1.45% | -0.70% | |||
| Average Diluted Shares Outstanding | -3.53% | -2.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||